Antithrombotic Treatment for Peripheral Arterial Occlusive Disease

CONCLUSION: Antiplatelet therapy should only be intensified for a limited time, or if the risk of ischemia is high. Before and during intensified antiplatelet therapy, the risk of bleeding should be assessed and weighed against the risk of ischemia. No validated score is available to estimate the risk of hemorrhagic complications in patients with PAOD. New antithrombotic therapies should not be used indiscriminately, but should rather be reserved for selected groups of patients.PMID:33734081 | DOI:10.3238/arztebl.m2021.0157
Source: Deutsches Arzteblatt International - Category: General Medicine Authors: Source Type: research